VeriMommagnolia kobus bark extract est-il sûr pendant la grossesse ?
No EU ban/restriction or harmonised CMR classification found for Magnolia kobus bark extract/CAS 223749-80-2 (CosIng entry exists), but animal studies on major Magnolia bark constituents (honokiol, magnolol) report embryo–fetal effects or placental/uterine effects in rodents, so reproductive hazard is suspected. Example studies: an embryo–fetal toxicity study of honokiol in pregnant rats and animal data showing magnolol alters placental morphology and can inhibit uterine contraction. CosIng/industry listings and EWG do not override these animal findings. Sources: PubMed studies and WHO monograph noted below.
Pregnancy-safe products containing magnolia kobus bark extract
Alternatives sûres à magnolia kobus bark extract pendant la grossesse | VeriMom
Related ingredients
Frequently asked questions
- magnolia kobus bark extract est-il sûr pendant la grossesse ?
- No EU ban/restriction or harmonised CMR classification found for Magnolia kobus bark extract/CAS 223749-80-2 (CosIng entry exists), but animal studies on major Magnolia bark constituents (honokiol, magnolol) report embryo–fetal effects or placental/uterine effects in rodents, so reproductive hazard is suspected. Example studies: an embryo–fetal toxicity study of honokiol in pregnant rats and animal data showing magnolol alters placental morphology and can inhibit uterine contraction. CosIng/industry listings and EWG do not override these animal findings. Sources: PubMed studies and WHO monograph noted below.
- magnolia kobus bark extract est-il sûr pendant l'allaitement ?
- No harmonised classification or EU Annex II/III listing found; however the same animal data and mechanistic evidence (placental/uterine activity and systemic activity of isolated constituents) justify a suspected hazard and demonstrated mechanism. Transfer into breastmilk is not directly studied for the extract, but systemic bioactivity of honokiol/magnolol supports cautious classification as suspected (h=2). Exposure from topical cosmetic use is likely low but measurable.
- magnolia kobus bark extract est-il sûr pour la peau de bébé ?
- Baby skin exposure: do not increase h or m without infant-specific evidence, but exposure score is increased because infant skin has higher absorption. The ingredient contains small lipophilic active constituents (honokiol/magnolol) with demonstrated systemic activity in animals; therefore exposure for 0–3 yr olds is scored higher (adult e=1 → baby e=2). No infant-specific safety studies located.
- Comment VeriMom évalue-t-il magnolia kobus bark extract ?
- VeriMom évalue magnolia kobus bark extract à 40/100 (risque moyen) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à magnolia kobus bark extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à magnolia kobus bark extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.